Hearing Impairments in Stage Five Chronic Kidney Disease Patients at Bogodogo University Teaching Hospital.

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

Hearing Impairments in Stage Five Chronic Kidney Disease Patients at Bogodogo University Teaching Hospital.

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Yasminatou BIKINGA byasminatou1987@gmail.com CHU Bogodogo Nephrology Ouaga Burkina Faso *

Co-author 2

Hanas Mama SIKA mamashanas@gmail.com CHU Bogodogo Nephrology Ouaga Burkina Faso -

Co-author 3

Adama Karambiri adamaroger@yahoo.fr CHU Bogodogo Nephrology Ouaga Burkina Faso -

Co-author 4

Co-author 5

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

We aims to study hearing impairments in patients with stage 5 CKD at CHU-B in order to identify factors associated with hearing impairments and to describe the types and degrees of hearing loss in these patients.

Methods

This was a cross-sectional descriptive study conducted from December 2023 to December 2024, including all patients diagnosed with stage 5 CKD followed at CHU-B during this study period

Results

A total of 60 patients were examined, of whom 30 patients were on hemodialysis for stage 5 CKD and 30 other stage 5 CKD patients were non-hemodialyzed out patients under conservative management. The study revealed that 21.67% had a hearing disorder, comprising 3.33% hemodialyzed patients and 18.34% non-hemodialyzed patients. The degree of hearing loss was represented respectively by 8.33% mild hearing loss, 10% moderate hearing loss, 1.67% severe hearing loss, and 1.67% profound hearing loss. Among these patients, 61.54% had sensorineural hearing loss and 38.46% had mixed hearing loss. Hemodialysis appears to be the only significant independent predictor of hearing impairment.

Conclusion

Several factors may be linked to the occurrence of hearing loss in stage 5 CKD patients, but hemodialysis appears to be the only independent predictive factor. Moderate sensorineural hearing loss is frequent in patients over 50 years of age, especially among non-hemodialyzed patients. Early prevention and a national study are necessary to improve management.

Kewords